Share Your Research, Maximize Your Social Impacts
Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis
Journal: Journal of Cardiovascular Medicine and Cardiology (Vol.4, No. 3)Publication Date: 2017-09-21
Authors : Nabila Ferahta Lukshe Kanagaratnam Moustapha Dramé Thomas Vogel Pierre-Jacques Ambrosi; Pierre-Olivier Lang;
Page : 038-048
Keywords : Oral Anticoagulants; Factor Xa Inhibitor; Antivitamin K; Bleeding Events; Major Bleeding; Gastrointestinal Bleeding; Intracranial Haemorrhage; Atrial Fibrillation; Meta-Analysis;
Source : Download
Find it from : Google Scholar
Abstract
Background: Randomized trials have shown that oral direct factor Xa inhibitors (ODIXa) offer potential advantages over vitamin K antagonists (VKAs). It is however unclear whether the magnitude of their benefi t is similar at the current recommended doses.
Other Latest Articles
- “C” Trouble: Class IC Anti-arrhythmic Toxicity
- Postoperative Atrial Fibrillation and its association with the Atrial Substrate and the electrophysiological properties of the Atrial Myocardium
- A rare case of Contusio Cordis: Fist fight leading to an Acute Myocardial Infarction due to Left Anterior Descending artery dissection
- Coronary Artery Bypass Surgery [CABG] Perspective Past, Present and Future
- Large Thrombotic Coronary Artery Aneurysm Treated With a Covered Stent Using OCT for Procedural Guidance
Last modified: 2018-09-05 15:22:11